Search Results - "Perpinyà Gombau, M"

5PSQ-061 New-onset multiple sclerosis associated with adalimumab treatment: about two case reports by Artime Rodríguez-Hermida, F, Perpinyà Gombau, M, Díez Vallejo, C, Olmo Martínez, M, Malla Canet, MD, Dordà Benito, A, Nogué Pujadas, E, Castellò Nòria, À, Sacrest Güell, R

“…Background and ImportanceTreatment with adalimumab offers an improvement in autoinmune diseases and it is considered well tolerated. Demyelination with…”
Get full text

4CPS-122 Clinical follow-up in patients with migraine after discontinuation of prophylactic biological treatment: a real-world experience by Díez Vallejo, C, Artime Rodríguez-Hermida, F, Perpinyà Gombau, M, Olmo Martínez, M, Coma Punset, M, Nogué Pujadas, E, Dordà Benito, A, Castellò Nòria, À, Sacrest Güell, R

“…Background and ImportanceMonoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway are recommended by European Headache Federation for…”
Get full text

4CPS-244 Cardiovascular, renal and bone evaluation of a HIV population over 60 years old by Artime Rodríguez-Hermida, F, Dordà Benito, A, Coma Punset, M, Perpinyà Gombau, M, Olmo Martínez, M, Malla Canet, MD, Mallart Romero, L, Sacrest Güell, R

“…Background and importanceAdvances in antiretroviral treatment (ART) have resulted in an increase in life expectancy in HIV patients. For this reason, a rise in…”
Get full text